Anesth Pain Med.  2023 Oct;18(4):447-448. 10.17085/apm.23018.

Electroconvulsive therapy and muscle relaxants

Affiliations
  • 1Department of Anesthesiology and Pain Medicine, Daejeon Eulgi University Hospital, School of Medicine, University of Eulji, Daejeon, Korea
  • 2Department of Anesthesiology and Pain Medicine, Asan Medical Center, School of Medicine, University of Ulsan, Seoul, Korea


Reference

1. Kaur M, Chhabra S, Bhatia P, Chouhan RS. Electroconvulsive therapy in a catatonia patient: succinylcholine or no succinylcholine? Anesth Pain Med (Seoul). 2022; 17:454–5.
2. Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand. 2012; 56:3–16.
3. Joung KW, Park DH, Jeong CY, Yang HS. Anesthetic care for electroconvulsive therapy. Anesth Pain Med (Seoul). 2022; 17:145–56.
Article
4. Martyn JA, White DA, Gronert GA, Jaffe RS, Ward JM. Up-and-down regulation of skeletal muscle acetylcholine receptors. effects on neuromuscular blockers. Anesthesiology. 1992; 76:822–43.
Article
5. Saricicek V, Sahin L, Bulbul F, Ucar S, Sahin M. Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression? J ECT. 2014; 30:30–4.
Article
Full Text Links
  • APM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr